A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting

UnknownOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

February 28, 2022

Conditions
AdultsHematological MalignancyOral Antineoplastic Agents
Interventions
BEHAVIORAL

Measure adherence behaviors

"Conducted in the ambulatory setting of two Brussels hospitals, the MADESIO mixed-method study design combine sequentially a first quantitative explorative questionnaire-based study with a second in depth qualitative approach.~The first 4 visits questionnaire-based survey prospectively measures adherence to OAMs and identify associated risk factors in the two sub-groups of ambulatory patients with various haematological malignancies. A combination of validated self-reported measures able to measure medication taking behaviours, assess both intentional and unintentional adherence, identify associated risk factors was selected.~The second qualitative phase, based on the McGill Illness narrative interview design, deeper address patients' therapeutic adherence and subjective meanings."

Trial Locations (2)

1000

CHU Saint Pierre, Brussels

Institut Jules Bordet, Brussels

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Université Libre de Bruxelles

OTHER

collaborator

Fondation Kisane

UNKNOWN

collaborator

Les Amis de l'Institut

UNKNOWN

lead

Jules Bordet Institute

OTHER